Parkinson Disease
Conditions
Keywords
Parkinson's disease, sport climbing, motor symptoms, training therapy
Brief summary
This controlled interventional study will investigate the effects of a 12-weeks sport climbing course compared to 24 weeks of unsupervised physical exercise on motor symptoms in Parkinson's disease
Detailed description
The primary aim of this study is to evaluate the effects of a 12-week sport climbing course versus unsupervised physical exercise on motor symptoms in patients with Parkinson's disease. Background: Sport climbing (SC) is known as a whole-body workout, which additionally trains cognitive, mental, and social abilities. In contrast to its public image, SC in a controlled environment using top-rope belay, is a safe sport and can be performed at any age and at any level. In the field of neurological rehabilitation, it is already used as therapeutic SC for other neurological diseases, such as stroke, multiple sclerosis, depressions etc. but studies on climbing in PD patients are lacking. Hypothesis: to find significant improvement of motor symptoms in the climbing group compared to the control group as well as biopsychosocial improvements after 6 weeks, 12 weeks, and 6 months after the intervention. Methods: Effects of SC on motor symptoms in 48 PD patients in total, who will be randomized into a climbing group (n=24) and a control group (n=24) will be evaluated. The climbing group will follow a 12-week 90 min/week climbing trainings course, led by professional climbing instructors. The control group will receive education/information material of the European physiotherapy guidelines for physical activity recommended by the WHO and will be instructed to follow the recommendation of the guidelines to independently live an active lifestyle and train unsupervised. All patients will be evaluated with clinical assessments at baseline, in between the study period (mid), after completing the 12-weeks study period (post). As additional outcomes, health benefits of SC in PD with a holistic approach, covering biopsychosocial aspects will be investigated. Therefore, non-motoric and motoric parameters will be evaluated, and follow-up assessments 6 months after.
Interventions
OTHERClimbing
The patients in the Climbing Group (CG) followed a 12-weeks long climbing trainings course in small groups of 3-4 participants with a certified climbing instructor.
OTHERUnsupervised activity group
The patients in the unsupervised activity group (UAG) received education European physiotherapy guidelines for physical activity recommended by the WHO of recommended activity and followed their self-selected activities over 12 weeks.
Sponsors
University of Vienna
University Hospital Schleswig-Holstein
Medical University of Vienna
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)
Masking description
Movement disorder specialists who performed the MDS-UPDRS III ratings were blinded to the group assignment.
Intervention model description
The participants were randomly assigned to either the climbng group or the unsupervised active group
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Idiopathic Parkinson's disease * HY stage 1-3
Exclusion criteria
* cognitive impairment * severe hearing or visual impairment * severe orthopedic problems
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical Rating | Testpoints: Change from Baseline Score after 12 weeks of the intervention | Motor Part of the Movement Disorders Society Unified Parkinson Disease Rating Scale (MDS-UPDRS) III |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quantified Bradykinesia test | Testpoints: Change after 12 weeks of the intervention | Changes in a quantified bradykinesia Tests by using a standardized speeded keyboard tapping task. Changes will be evaluates in keys/second |
| Hand grip strength | Testpoints: Change after 12 weeks of the intervention | Assessment of hand grip strength, using a dynamometer. Results will be evaluated in Kilogramms |
| Parkinson Quality of Life Questionaire-39 (PDQ-39) | Testpoints: Change after 12 weeks of the intervention | Quality of life, assessed by the PDQ-39 Questionnaire |
| Change in Gait and Balance using wearable sensors | Testpoints: Change after 12 weeks of the intervention | Inertial Sensors will be used to quantify gait metrics (postural sway, gait cycle, speed) as participants conduct walking and balance trials |
| Cognitive assessments | Testpoints: Change after 12 weeks of the intervention | Change in cognition will be assessed using a standardized cognitive assessment battery, measuring following domains: executive functions, memory, attention and verbal functions |
| Changes in brain functional and structural MRI (resting state paradigma) and Changes in brain structural and functional MRI | Testpoints: Change after 12 weeks of the intervention | Changes in structural and functional MRI (resting state paradigma) will be assessed |
| Social Outcomes | Testpoints: Change after 12 weeks of the intervention | Questionnaiers about social effects |
Countries
Austria
Outcome results
None listed